United States

People: Cepheid (CPHD.OQ)

CPHD.OQ on NASDAQ Stock Exchange Global Select Market

27 Jul 2016
Change (% chg)

$0.31 (+0.95%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Steele, Glenn 

Dr. Glenn D. Steele, Jr., M.D., Ph.D., is an Independent Director of Cepheid., since April 26, 2011. Dr. Steele has served as President and Chief Executive Officer of Geisinger Health System, a physician-led health care system serving multiple regions of Pennsylvania, since March 2001. Prior to that, he was at the University of Chicago where he served as the Richard T. Crane Professor in the Department of Surgery, Vice President for Medical Affairs, and Dean of the Biological Sciences Division and of the Pritzker School of Medicine. Dr. Steele also serves on the boards of Bucknell University, Weis Markets Inc., Wellcare Health Plans Inc., xG Health Solutions, Inc. as Chairman and Millennium Health, Inc. and on the Business Advisory Board for Third Rock Ventures, LLC. Dr. Steele has extensive experience in the health care industry, as a noted surgeon, researcher and hospital group administrator. Additionally, his experience as chief executive officer of an integrated health care system brings a useful perspective as hospitals and other health care providers are key customers of our clinical diagnostics products. His significant research into the diagnosis and treatment of cancer assists the Board in refining our research programs, product development efforts and commercial strategy in the oncology field.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

John Bishop


Warren Kocmond


Daniel Madden


David Persing


Peter Farrell


Michael Fitzgerald

As Of  30 Dec 2014